Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TP53 Y220C refers to the tumor protein p53 with a tyrosine-to-cysteine substitution at position 220, a recurrent hotspot mutation in cancers including AML and MDS. This structural mutation creates a unique hydrophobic surface crevice or pocket in the DNA-binding domain, reducing thermal stability (melting at physiological temperatures), impairing DNA binding, promoting denaturation and aggregation, and abrogating wild-type p53 tumor suppressor functions. Small molecules like PC14586 bind this pocket to refold the protein into wild-type-like conformation, reactivate transcriptional targets (e.g., MDM2, p21), and induce signaling, though full apoptotic efficacy requires combinations targeting MDM2, XPO1, or BCL-2 due to mechanistic limitations. The query specifies a "TP53 Y220C/HLA complex," but no search results describe such a complex; available data focus solely on the isolated mutant p53 protein or its small-molecule-bound structures (e.g., PDB 6GGC), indicating the complex may be non-standard, hypothetical, or undocumented here.
Binds hydrophobic pocket created by Y220C mutation to stabilize wild-type conformation, Restore p53 transcriptional activity, Increase thermal stability, Decrease aggregation, Reactivate p53 signaling
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor protein p53 Tyr220Cys mutant (TP53 Y220C) (TP53 Y220C).